Eclipse Ventures Fund I, L.P. 4
Accession 0001193125-25-240517
Filed
Oct 14, 8:00 PM ET
Accepted
Oct 15, 6:56 PM ET
Size
23.4 KB
Accession
0001193125-25-240517
Insider Transaction Report
- Award
Common Stock
2025-10-10+3,898,906→ 5,665,669 total(indirect: See footnote) - Disposition to Issuer
Series A Warrants (Right to Purchase Shares of Common Stock)
2025-10-10−5,300,291→ 0 total(indirect: See footnote)→ Common Stock (5,300,291 underlying) - Disposition to Issuer
Series B Warrants (Right to Purchase Shares of Common Stock)
2025-10-10−1,166,935→ 0 total(indirect: See footnote)→ Common Stock (1,166,935 underlying)
- 968,694(indirect: See footnote)
Common Stock
- 1,066,472(indirect: See footnote)
Common Stock
- Award
Common Stock
2025-10-10+3,898,906→ 5,665,669 total(indirect: See footnote) - Disposition to Issuer
Series A Warrants (Right to Purchase Shares of Common Stock)
2025-10-10−5,300,291→ 0 total(indirect: See footnote)→ Common Stock (5,300,291 underlying) - Disposition to Issuer
Series B Warrants (Right to Purchase Shares of Common Stock)
2025-10-10−1,166,935→ 0 total(indirect: See footnote)→ Common Stock (1,166,935 underlying)
- 968,694(indirect: See footnote)
Common Stock
- 1,066,472(indirect: See footnote)
Common Stock
- Award
Common Stock
2025-10-10+3,898,906→ 5,665,669 total(indirect: See footnote) - Disposition to Issuer
Series A Warrants (Right to Purchase Shares of Common Stock)
2025-10-10−5,300,291→ 0 total(indirect: See footnote)→ Common Stock (5,300,291 underlying) - Disposition to Issuer
Series B Warrants (Right to Purchase Shares of Common Stock)
2025-10-10−1,166,935→ 0 total(indirect: See footnote)→ Common Stock (1,166,935 underlying)
- 968,694(indirect: See footnote)
Common Stock
- 1,066,472(indirect: See footnote)
Common Stock
- Disposition to Issuer
Series B Warrants (Right to Purchase Shares of Common Stock)
2025-10-10−1,166,935→ 0 total(indirect: See footnote)→ Common Stock (1,166,935 underlying) - Award
Common Stock
2025-10-10+3,898,906→ 5,665,669 total(indirect: See footnote) - Disposition to Issuer
Series A Warrants (Right to Purchase Shares of Common Stock)
2025-10-10−5,300,291→ 0 total(indirect: See footnote)→ Common Stock (5,300,291 underlying)
- 968,694(indirect: See footnote)
Common Stock
- 1,066,472(indirect: See footnote)
Common Stock
- Award
Common Stock
2025-10-10+3,898,906→ 5,665,669 total(indirect: See footnote) - Disposition to Issuer
Series A Warrants (Right to Purchase Shares of Common Stock)
2025-10-10−5,300,291→ 0 total(indirect: See footnote)→ Common Stock (5,300,291 underlying) - Disposition to Issuer
Series B Warrants (Right to Purchase Shares of Common Stock)
2025-10-10−1,166,935→ 0 total(indirect: See footnote)→ Common Stock (1,166,935 underlying)
- 968,694(indirect: See footnote)
Common Stock
- 1,066,472(indirect: See footnote)
Common Stock
- Disposition to Issuer
Series A Warrants (Right to Purchase Shares of Common Stock)
2025-10-10−5,300,291→ 0 total(indirect: See footnote)→ Common Stock (5,300,291 underlying) - Disposition to Issuer
Series B Warrants (Right to Purchase Shares of Common Stock)
2025-10-10−1,166,935→ 0 total(indirect: See footnote)→ Common Stock (1,166,935 underlying) - Award
Common Stock
2025-10-10+3,898,906→ 5,665,669 total(indirect: See footnote)
- 968,694(indirect: See footnote)
Common Stock
- 1,066,472(indirect: See footnote)
Common Stock
Footnotes (4)
- [F1]On October 10, 2025, Eclipse Early Growth Fund I, L.P. ("Eclipse EGF I") exchanged (a) warrants to purchase shares of Class A common stock, par value $0.0001 per share, of the Company (the "Common Stock"), that were initially issued in February 2023 in connection with the Company's issuance and sale of Series A Convertible Preferred Stock and (b) warrants to purchase shares of Common Stock that were initially issued in February 2024 in connection with the Company's issuance and sale of Series B Convertible Preferred Stock for the shares of Common Stock reported herein at a ratio of approximately 0.61 and 0.56 shares per warrant, respectively. The disposition or deemed disposition of the warrants and any shares of Common Stock that may have been be acquired upon exercise of such warrants and the acquisition of Common Stock in this exchange were exempted from Section 16(b) of the Act pursuant to Rule 16b-3 thereunder.
- [F2]The securities are held of record by Eclipse EGF I. Eclipse Early Growth GP I, LLC ("Eclipse EG GP I") is the general partner of Eclipse EGF I and may be deemed to have voting and dispositive power over the shares held by Eclipse EGF I. Mr. Susan is the sole managing member of Eclipse EG GP I and may be deemed to have voting and dispositive power over the shares held by Eclipse EGF I. Eclipse EG GP I and Mr. Susan disclaim beneficial ownership of the shares held by Eclipse EGF I except to the extent of their respective pecuniary interests therein, if any.
- [F3]The securities are held of record by Eclipse Ventures Fund I, L.P. ("Eclipse I"). Eclipse Ventures GP I, LLC ("Eclipse I GP") is the general partner of Eclipse I and may be deemed to have voting and dispositive power over the shares held by Eclipse I. Lior Susan, a member of the Issuer's board of directors, is the sole managing member of Eclipse I GP and may be deemed to have voting and dispositive power over the shares held by Eclipse I. Eclipse I GP and Mr. Susan disclaim beneficial ownership of the shares held by Eclipse I except to the extent of their respective pecuniary interests therein, if any.
- [F4]The securities are held of record by Eclipse Continuity Fund I, L.P. ("Eclipse Continuity I", and collectively with Eclipse EGF I and Eclipse I, the "Eclipse Funds"). Eclipse Continuity GP I, LLC ("Eclipse Continuity GP") is the general partner of Eclipse Continuity I and may be deemed to have voting and dispositive power over the shares held by Eclipse Continuity I. Mr. Susan, a member of the Issuer's board of directors, is the sole managing member of Eclipse Continuity GP and may be deemed to have voting and dispositive power over the shares held by Eclipse Continuity I. Eclipse Continuity GP and Mr. Susan disclaim beneficial ownership of the shares held by Eclipse Continuity I except to the extent of their respective pecuniary interests therein, if any.
Documents
Issuer
Owlet, Inc.
CIK 0001816708
Related Parties
1- filerCIK 0001641394
Filing Metadata
- Form type
- 4
- Filed
- Oct 14, 8:00 PM ET
- Accepted
- Oct 15, 6:56 PM ET
- Size
- 23.4 KB